Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1195812

In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery


Nižić Nodilo, Laura; Perkušić, Mirna; Ugrina, Ivo; Špoljarić, Drago; Jakobušić Brala, Cvijeta; Amidžić Klarić, Daniela; Lovrić, Jasmina; Saršon, Vesna; Safundžić Kučuk, Maša; Zadravec, Dijana et al.
In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery // European journal of pharmaceutics and biopharmaceutics, 175 (2022), 27-42 doi:10.1016/j.ejpb.2022.04.009 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1195812 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery

Autori
Nižić Nodilo, Laura ; Perkušić, Mirna ; Ugrina, Ivo ; Špoljarić, Drago ; Jakobušić Brala, Cvijeta ; Amidžić Klarić, Daniela ; Lovrić, Jasmina ; Saršon, Vesna ; Safundžić Kučuk, Maša ; Zadravec, Dijana ; Kalogjera, Livije ; Pepić, Ivan ; Hafner, Anita

Izvornik
European journal of pharmaceutics and biopharmaceutics (0939-6411) 175 (2022); 27-42

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
in situ gelling ; nanosuspension ; fluticasone propionate ; nasal drug delivery ; 3D printed nasal cavity model ; chronic rhinosinusitis

Sažetak
In this work we present the development of in situ gelling nanosuspension as an advanced form for fluticasone propionate nasal delivery. Drug nanocrystals were prepared by wet milling technique. Incorporation of drug nanocrystals into polymeric in situ gelling system with pectin and sodium hyaluronate as constitutive polymers was fine-tuned attaining appropriate formulation surface tension, viscosity and gelling ability. Drug nanonisation improved the release profile and enhanced formulation mucoadhesive properties. QbD approach combining formulation and administration parameters resulted in optimised nasal deposition profile, with 51.8% of the dose deposited in the middle meatus, the critical region in the treatment of rhinosinusitis and nasal polyposis. Results obtained in biocompatibility and physico- chemical stability studies confirmed the leading formulation potential for safe and efficient nasal corticosteroid delivery.

Izvorni jezik
Engleski

Znanstvena područja
Farmacija



POVEZANOST RADA


Projekti:
HRZZ-UIP-2017-05-4592 - Optimiranje depozicije raspršenih in situ gelirajućih i praškastih terapijskih sustava u nosnoj šupljini (OptiNasalSpray) (Hafner, Anita, HRZZ - 2017-05) ( CroRIS)
EK-EFRR-KK.01.1.1.02.0021 - Jačanje znanstveno-istraživačkih i inovacijskih kapaciteta Farmaceutsko-biokemijskog fakulteta Sveučilišta u Zagrebu (FarmInova) (Lovrić, Jasmina, EK - Ulaganje u organizacijsku reformu i infrastrukturu u sektoru istraživanja, razvoja i inovacija) ( CroRIS)

Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Stomatološki fakultet, Zagreb,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Prirodoslovno-matematički fakultet, Split

Poveznice na cjeloviti tekst rada:

doi doi.org www.sciencedirect.com

Citiraj ovu publikaciju:

Nižić Nodilo, Laura; Perkušić, Mirna; Ugrina, Ivo; Špoljarić, Drago; Jakobušić Brala, Cvijeta; Amidžić Klarić, Daniela; Lovrić, Jasmina; Saršon, Vesna; Safundžić Kučuk, Maša; Zadravec, Dijana et al.
In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery // European journal of pharmaceutics and biopharmaceutics, 175 (2022), 27-42 doi:10.1016/j.ejpb.2022.04.009 (međunarodna recenzija, članak, znanstveni)
Nižić Nodilo, L., Perkušić, M., Ugrina, I., Špoljarić, D., Jakobušić Brala, C., Amidžić Klarić, D., Lovrić, J., Saršon, V., Safundžić Kučuk, M. & Zadravec, D. (2022) In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery. European journal of pharmaceutics and biopharmaceutics, 175, 27-42 doi:10.1016/j.ejpb.2022.04.009.
@article{article, author = {Ni\v{z}i\'{c} Nodilo, Laura and Perku\v{s}i\'{c}, Mirna and Ugrina, Ivo and \v{S}poljari\'{c}, Drago and Jakobu\v{s}i\'{c} Brala, Cvijeta and Amid\v{z}i\'{c} Klari\'{c}, Daniela and Lovri\'{c}, Jasmina and Sar\v{s}on, Vesna and Safund\v{z}i\'{c} Ku\v{c}uk, Ma\v{s}a and Zadravec, Dijana and Kalogjera, Livije and Pepi\'{c}, Ivan and Hafner, Anita}, year = {2022}, pages = {27-42}, DOI = {10.1016/j.ejpb.2022.04.009}, keywords = {in situ gelling, nanosuspension, fluticasone propionate, nasal drug delivery, 3D printed nasal cavity model, chronic rhinosinusitis}, journal = {European journal of pharmaceutics and biopharmaceutics}, doi = {10.1016/j.ejpb.2022.04.009}, volume = {175}, issn = {0939-6411}, title = {In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery}, keyword = {in situ gelling, nanosuspension, fluticasone propionate, nasal drug delivery, 3D printed nasal cavity model, chronic rhinosinusitis} }
@article{article, author = {Ni\v{z}i\'{c} Nodilo, Laura and Perku\v{s}i\'{c}, Mirna and Ugrina, Ivo and \v{S}poljari\'{c}, Drago and Jakobu\v{s}i\'{c} Brala, Cvijeta and Amid\v{z}i\'{c} Klari\'{c}, Daniela and Lovri\'{c}, Jasmina and Sar\v{s}on, Vesna and Safund\v{z}i\'{c} Ku\v{c}uk, Ma\v{s}a and Zadravec, Dijana and Kalogjera, Livije and Pepi\'{c}, Ivan and Hafner, Anita}, year = {2022}, pages = {27-42}, DOI = {10.1016/j.ejpb.2022.04.009}, keywords = {in situ gelling, nanosuspension, fluticasone propionate, nasal drug delivery, 3D printed nasal cavity model, chronic rhinosinusitis}, journal = {European journal of pharmaceutics and biopharmaceutics}, doi = {10.1016/j.ejpb.2022.04.009}, volume = {175}, issn = {0939-6411}, title = {In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery}, keyword = {in situ gelling, nanosuspension, fluticasone propionate, nasal drug delivery, 3D printed nasal cavity model, chronic rhinosinusitis} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font